# OnCo record nct05334823 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05334823/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05334823", "NCT05334823" ;
  schema:name "A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents"@en ;
  schema:description "A phase 2 trial of pCAR-19B cells in acute lymphoblastic leukaemia and childhood cancers, run by Chongqing Precision Biotech Co., Ltd, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05334823/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05334823> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2022-01-26" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/childhood-cancers/>, <https://onco.cc/cancers/all-paediatric-relapsed/> ;
  onco:companies <https://onco.cc/companies/chongqing-precision-biotech/> .